Northwest Biotherapeutics Articles
NWBT highlights cost effectiveness of DCVax in view of recent immunotherapy pricing concerns
11 August 2011
"Cancer vaccine revolution" seeing most striking data from Northwest Biotherapeutics, says analyst
29 June 2010
Showing 1-3 of 3 articles
- 1
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
